Yaming Guo

1095 Jiefang Avenue
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

An ANGPTL8-AKT2-mTOR Axis Drives Adipose Senescence and Aging-Related Functional Decline.

An ANGPTL8-AKT2-mTOR Axis Drives Adipose Senescence and Aging-Related Functional Decline.

Journal: Aging cell

Published: March 10, 2026

Associations between cholesterol, high-density lipoprotein, and glucose index and hyperuricemia in patients with diabetes.

Associations between cholesterol, high-density lipoprotein, and glucose index and hyperuricemia in patients with diabetes.

Journal: BMC endocrine disorders

Published: January 28, 2026

Gabpα-Pparγ Complex Determines Glycolytic Capacity and Lactic Acid Homeostasis in Brown Fat.

Gabpα-Pparγ Complex Determines Glycolytic Capacity and Lactic Acid Homeostasis in Brown Fat.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 06, 2025

The impact of semaglutide on liver outcomes in patients with or at risk of MASH: a dose and duration response meta-analysis of randomized trials.

The impact of semaglutide on liver outcomes in patients with or at risk of MASH: a dose and duration response meta-analysis of randomized trials.

Journal: Diabetology & metabolic syndrome

Published: July 17, 2025

Angiopoietin-like protein 8 mediates inflammation and fibrosis of tubular cells in diabetic kidney disease progression by interacting with Akt2.

Angiopoietin-like protein 8 mediates inflammation and fibrosis of tubular cells in diabetic kidney disease progression by interacting with Akt2.

Journal: Metabolism: clinical and experimental

Published: March 31, 2025

Angiopoietin-like 8 governs osteoblast-adipocyte lineage commitment during skeletal aging.

Angiopoietin-like 8 governs osteoblast-adipocyte lineage commitment during skeletal aging.

Journal: JCI insight

Published: November 18, 2024

Risk Factors, Pathological Changes, and Potential Treatment of Diabetes-Associated Cognitive Dysfunction.

Risk Factors, Pathological Changes, and Potential Treatment of Diabetes-Associated Cognitive Dysfunction.

Journal: Journal of diabetes

Published: November 08, 2024

The modified role including mediating and synergistic interactive effects of glucose tolerance status in the associations between relative fat mass and the risks of cardiovascular disease and all-cause mortality from the 4C cohort study.

The modified role including mediating and synergistic interactive effects of glucose tolerance status in the associations between relative fat mass and the risks of cardiovascular disease and all-cause mortality from the 4C cohort study.

Journal: Diabetology & metabolic syndrome

Published: September 24, 2024

Association between estimated glucose disposal rate and kidney function decline in different glucose tolerance statuses from the 4 C study.

Association between estimated glucose disposal rate and kidney function decline in different glucose tolerance statuses from the 4 C study.

Journal: Acta diabetologica

Published: August 23, 2024

Associations of physiologic subtypes based on HOMA2 indices of β-cell function and insulin sensitivity with the risk of kidney function decline, cardiovascular disease, and all-cause mortality from the 4C study.

Associations of physiologic subtypes based on HOMA2 indices of β-cell function and insulin sensitivity with the risk of kidney function decline, cardiovascular disease, and all-cause mortality from the 4C study.

Journal: Cardiovascular diabetology

Published: August 22, 2024

The mediating role of remnant cholesterol in the associations of Angiopoietin-like 8 with all-cause, CVD, and cancer death: the China Cardiometabolic Disease and Cancer Cohort (4C) study.

The mediating role of remnant cholesterol in the associations of Angiopoietin-like 8 with all-cause, CVD, and cancer death: the China Cardiometabolic Disease and Cancer Cohort (4C) study.

Journal: Endocrine

Published: July 27, 2024

Inhibition of ANGPTL8 protects against diabetes-associated cognitive dysfunction by reducing synaptic loss via the PirB signaling pathway.

Inhibition of ANGPTL8 protects against diabetes-associated cognitive dysfunction by reducing synaptic loss via the PirB signaling pathway.

Journal: Journal of neuroinflammation

Published: January 22, 2024

Showing 1-12 of 15

Last Updated: 09/26/2026